Drug‐drug interaction concerns raised: ADHD a focus

Alison Knopf

doi:10.1002/cbl.30948

April 13, 2026The Brown University Child and Adolescent Behavior Letter

Drug‐drug interaction concerns raised: ADHD a focus

View at Publisher

Ask AI

Bookmark

Share

Key Points

The aim is to assess the prevalence of drug-drug interactions in youth undergoing treatment with psychotropic medications.
Analyzed data from a two-decade period ending in 2020.
Evaluated exposure to contraindicated or major drug-drug interactions in youth.
Focused on medication safety and effectiveness.
One in four youth experienced potential contraindicated drug-drug interactions.
The findings indicate a significant risk associated with psychotropic medications in adolescents.

Implication

Researchers report potential drug-drug interactions in youth treated with psychotropic medications, highlighting safety concerns.

Abstract

One in four youth treated with psychotropic medications were exposed to potential contraindicated or major drug‐drug interactions (DDIs) during the two‐decade period ending in 2020, researchers have found. They urge that studies be conducted focusing on medication safety, effectiveness, and DDI risks of psychotropic medications in youth.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Alison Knopf (2026) studied this question.

synapsesocial.com/papers/69df2b65e4eeef8a2a6b056c https://doi.org/10.1002/cbl.30948

View at Publisher

Ask AI

Bookmark

Share

Drug‐drug interaction concerns raised: ADHD a focus

Key Points

Implication

Abstract

Discussion

Cite This Study

Drug‐drug interaction concerns raised: ADHD a focus

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading